For instance, a large network meta-analysis showed that SGLT-2 inhibitors reduced hospitalization for HF and renal composite outcome more than GLP-1RA [15], and that in patients with cardiovascular disease, SGLT-2 inhibitors show significant reduction in both heart failure (HF) hospitalizations and mortality for patients with HF and reduced ejection fraction [16]
Patterns of cutaneous nerve fibre loss and regeneration in type 2 diabetes with painful and painless polyneuropathy
Fibromyalgia treatments frequently include a combination of medicines, non-pharmacological therapies, and lifestyle changes
Le P, Tatar M, Dasarathy S, Alkhouri N, Herman WH, Taksler GB, et al
WHAT ARE B12 INJECTIONS
FOR EFFECTS OF GLP-1 MEDICATIONS MAY NOT BE PERMANENT SOURCE: National Institute of Diabetes and Digestive and Kidney Diseases